• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • New Medical Device Classification Catalogue in Draft

New Medical Device Classification Catalogue in Draft

Monday, 20 December 2021 / Published in Medical Device, News, NMPA Registration in China

New Medical Device Classification Catalogue in Draft

On November 9, 2021, the NIFDC (National Institutes for Food and Drug Control) announced the draft classification catalogue for medical devices.

Highlights

  • The following products were added:
    • 02-11-03 expander
    • 13-11-04 tissue-induced implant devices
    • 13-11-05 containing chitin intraarticular fluid
    • 17-06-03 Metal and ceramic denture materials for additive manufacturing
    • 17-08-05 implant AIDS
  • The description of the following products were modified:
    •  03-05-02 hemostatic clip
    • 08-05-15 oxygen inhaler
    • 17-10-06 tooth bleaching material
    • 18-06-03 screen contraceptive device
    • 22-02-01 biochemical analysis instrument
    • 22-06-05 Microbial mass spectrometry identification instrument
    • 22-10-04 liquid chromatography analysis instrument
  • 04-05-01 probe changed from Class III to Class II
  • Revised the intended use of 04-12-01 orthopedic dynamic surgical equipment
  • Revised secondary product category, product description, expected use, product name example for 06-01-06 mobile C-arm X-ray machine
  • Modified expected use, product name examples of 07-04-01 patient monitoring equipment
  • Modified Sample names of 09-07-02 radiofrequency superficial therapy device, 13-05-02 Calcium salt bone Implant, 13-09-01 Plastic implant, 14-01-06, 22-04-09 biochemical immunoassay devices;
  • Modified the product description and management category of 16-04-01 ophthalmic laser diagnostic equipment;
  • Amended secondary product category, product description, intended use, sample product name, management category of 17-03-08 Tooth bleaching equipment
  • Modified the first class product category of 18-06 pregnancy control device
  • Modified product description and product name examples of 22-04-05 immunoblotting instrument
  • Modified product description, intended use, product name examples of 22-05-03 nucleic acid amplification analyzer, 22-07-02 Image scanning instrument, 22-10-03 Mass spectrometry Detection system, 09-07-01 RF hyperthermia device, 13-09-02 Plastic injection fillers
  • Modified secondary product category, product description, intended use, product name example of 22-15-02 counter board

Read our blog post about the In Vitro Diagnostic Reagents Classification Rules that was published by the NMPA as a standalone document for the first time.

By Alice Liu and Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Classification Catalogue

What you can read next

The Amended Drug Administration Law
Measures for the supervision and administration of drug production
Measures for the Supervision and Administration of Drug Production in China – A Recap
Cisema Webinar on Cosmetics Registration
Cisema Webinar on Cosmetics Registration – Under China’s New Regulatory Framework

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.